Overview
Jeffrey Allen is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Neurofibromatosis, Glioma, Pineoblastoma, and Neurofibromatosis Type 1 (NF1).
His clinical research consists of co-authoring 70 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Diffuse Midline Glioma H3 K27M-Mutant.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Allen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Ira Dunkel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Brain Stem Cancer.
Kim Kramer is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Kramer is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.
Nai-kong Cheung is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Cheung is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Desmoplastic Small Round Cell Tumor, and Diffuse Midline Glioma H3 K27M-Mutant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- NeurofibromatosisDr. Allen isElite. Learn about Neurofibromatosis.
- Advanced
- Diffuse Midline Glioma H3 K27M-Mutant
- Germ Cell TumorDr. Allen isAdvanced. Learn about Germ Cell Tumor.
- GliomaDr. Allen isAdvanced. Learn about Glioma.
- Neurofibromatosis Type 1 (NF1)Dr. Allen isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- Optic GliomaDr. Allen isAdvanced. Learn about Optic Glioma.
- PineoblastomaDr. Allen isAdvanced. Learn about Pineoblastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Allen isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Brain Stem CancerDr. Allen isExperienced. Learn about Brain Stem Cancer.
- Embryonal Tumor with Multilayered Rosettes
- Infantile NeutropeniaDr. Allen isExperienced. Learn about Infantile Neutropenia.
- Malignant Peripheral Nerve Sheath Tumor
- MedulloblastomaDr. Allen isExperienced. Learn about Medulloblastoma.